Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 6,755 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Hematopoietic Stem Cell Transplantations
Interventions: autoRIC®; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 10 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hearing Loss
Interventions: Lyric extended wear hearing aid device A, Lyric extended wear hearing aid with fitting modification device B; Device
Lead sponsor: Sonova AG; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Narberth, Pennsylvania

Conditions: Highly Sensitized Prospective Kidney Transplant Recipients
Interventions: carfilzomib, belatacept, Bone marrow aspiration; Biological · Procedure
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hypertension
Interventions: Heart Health and Nutrition for Life (HHNL), Self-Measured Blood Pressure; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 84 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Lower Extremity Amputation
Interventions: Dynamic Air Exchange - Rising Edge Design (DAE-RED), Perforated elastomeric liner, As-prescribed prosthesis; Device
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal Adenocarcinoma
Interventions: Givastomig, Nivolumab, 5Fluorouracil, Leucovorin, Oxaliplatin, Capecitabine; Drug
Lead sponsor: I-Mab Biopharma US Limited; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Goodyear, Arizona • Duarte, California • Boston, Massachusetts

Conditions: Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3
Interventions: Vepugratinib; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Myrtle Beach, South Carolina

Conditions: Childhood Cancer
Interventions: One-time blood draw, Evaluation of CpG methylation, Metabolomic analysis; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 1 Year to 18 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pre-term Infants
Interventions: study pre-term formula; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: Up to 21 Days
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 7
States / cities: Mobile, Alabama • South Bend, Indiana • Wichita, Kansas + 4 more

Conditions: Impaired Glucose Tolerance, Prediabetes
Interventions: CGM; Device
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 10 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Bone Sarcoma, Childhood Cancer
Interventions: Cognitive Behavior Therapy, Transcranial Direct Current Stimulation, Placebo Administration, Questionnaire Administration, Interview; Behavioral · Device · Drug + 1 more
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 10 Years and older
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Breast Neoplasms
Interventions: Re-Patterning Sitting Time Group, Reducing Sitting Time Group, Usual Care; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Depression, Anxiety, Palliative Care, Caregivers, Cancer
Interventions: Problem-Solving Therapy, Attention-matched Control, In-depth interviews; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 532 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Columbia, Missouri • St Louis, Missouri • Philadelphia, Pennsylvania

Conditions: Stroke
Interventions: Telerehabilitation; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 85 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 27
States / cities: Downey, California • Irvine, California • Los Angeles, California + 20 more

Conditions: Volume Deficiency in the Mid-Face, Skin Laxity, Photo-aged Skin
Interventions: Sculptra®; Device
Lead sponsor: Galderma R&D; Industry
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoporosis
Interventions: BZA 20 mg/CE 0.45 mg, BZA 20 mg/CE 0.625 mg, Raloxifene 60 mg, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 40 Years to 75 Years · Female only
Enrollment: 507 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 22
States / cities: Fort Myers, Florida • Gainesville, Florida • New Port Richey, Florida + 19 more

Conditions: Blood Pressure, Dental Anxiety
Interventions: Intravenous Sedatives with or Without Analgesia, No IV sedation; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Hennepin County Medical Center, Minneapolis; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Neurological Disorders
Interventions: Functional Electrical Stimulation (FES) Control Protocol, Functional Electrical Stimulation (FES) Angle Protocol; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Insomnia, Sleep Disorder, Dyssomnia
Interventions: propofol injectable emulsion; Drug
Lead sponsor: Life Extension Foundation Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Inflammatory Bowel Diseases
Interventions: The IBD-AID; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 15 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Osteoporosis
Interventions: Diet with increased fruits, vegetables, and calcium, Increased high impact activity and resistance training; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 14 Years to 16 Years · Female only
Enrollment: 228 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Substance Use Disorder (SUD), Opioid Use Disorders, Stimulant Overdose, Overdose Risk, Alcohol Use Disorder
Interventions: Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters), Recovery Management Checkups (RMC) delivered by staff under the research team (RMC by research staff); Behavioral
Lead sponsor: Chestnut Health Systems; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Type 2, Pre-diabetes
Interventions: Intermittent Fasting; Other
Lead sponsor: gino gaddini; Federal
Eligibility: 18 Years to 69 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Search by objective public record fields.

Remote Ischemic Conditioning in HSCT

Evaluation of Extended Wear Technology

Carfilzomib and Belatacept for Desensitization

WEAVE NM: Heart Health and Nutrition for Life

Adherence and Perspiration While Wearing Lower Limb Prostheses

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

Epigenetic and Metabolomic Changes in Childhood Cancer Survivors

Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer

The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors

Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care

Telerehabilitation In The Home After Stroke

A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging

Study Evaluating Changes In Mammographic Breast Density

Hemodynamic Changes During Implant Surgery with Intravenous Conscious Sedation

Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study

Muscle Delay Characterization

Efficacy and Safety Study of Propofol Infusion for Refractory Chronic Primary Insomnia

The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)

Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study

Recovery Management Checkup Scalability and Sustainability Hybrid Experiment

Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study